Magnolia Medical Alleges Patent Infringement by Kurin in Blood Collection Tech Dispute

Mar 11, 2019

|

NEW YORK (360Dx) – Magnolia Medical Technologies is alleging Kurin is infringing four patents covering Maganolia's blood collection device.

Last week, Magnolia amended a complaint filed in the US District Court for the District of Delaware to allege that Kurin is infringing four Magnolia patents — US Patent No. 9,855,001, US Patent No. 10,028,689, US Patent No. 10,039,483, and US Patent No. 10,220,139 — covering its blood collection platform.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Breaking News

Jul

23

Featured Webinar

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients.

Jul

30

Featured Webinar

Single-Cell Sequencing Reveals Clonal Heterogeneity in Acute Lymphoblastic Leukemia

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

Menu